Pharmacology, Toxicology and Pharmaceutical Science
Dimer
100%
Guanine
81%
Antibody Drug Conjugate
68%
Anthramycin
68%
Clerodane Derivative
54%
Transcription Factor
54%
DNA Fragment
54%
Monomer
54%
Breast Cancer
54%
Carcinogenesis
54%
Clinical Trial
45%
Base
36%
Oligonucleotide
31%
Tinospora
27%
Diterpene
27%
Leukemia
27%
Cyclin D1
27%
Neoplasm
27%
Ovary Cancer
27%
Fascin
27%
Carbon 11
27%
High Performance Liquid Chromatography
22%
Natural Product
18%
Non-Covalent Interactions
9%
Malignant Neoplasm
9%
STAT3 Protein
9%
DNA Base
9%
Imine
9%
Medicine and Dentistry
Dimer
100%
Guanine
81%
Anthramycin
68%
Antibody-Drug Conjugate
68%
Monomer
54%
Double Stranded DNA
54%
DNA Fragment
54%
Transcription Factor
54%
Carcinogenesis
54%
Clinical Trial
45%
Base
36%
Oligonucleotide
31%
Carbon 11
27%
Ovarian Cancer
27%
Benzodiazepine Derivative
27%
DNA Binding
22%
Liquid Chromatography-Mass Spectrometry
22%
Pre-Clinical Development
18%
Neoplasm
18%
Patient with Leukemia
18%
Natural Product
18%
Skeleton
13%
DNA Strand
13%
Imine
9%
Cancer Cell
9%
Cross-Link
9%
Leukemia
9%
Tumor Cell Line
9%
Regulatory Region
9%
Consensus Sequence
9%
STAT3 Protein
9%
Gene Linkage
9%
DNA Base
9%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
63%
STAT3
63%
Transcription Factor
54%
Carcinogenesis
54%
Dimerization
54%
Oligonucleotide
18%
Alkylation
18%
Electrophilicity
9%
Small Molecule
9%
Guanine
9%
Regulatory Region
9%
Consensus Sequence
9%
DNA Binding
9%
GC-content
9%
Tinospora
9%
Gene Linkage
9%
Liquid Chromatography-Mass Spectrometry
9%
Clinical Trial
9%
Cross-Link
9%
Cyclin D1
9%
SH2 Domain
9%
Fascin
9%
Docking (Molecular)
9%
Bcl-2
9%